Literature DB >> 26303701

Epidemiology of Neuroendocrine Tumors.

Merav Fraenkel1, Antongiulio Faggiano, Gerlof D Valk.   

Abstract

Formerly named carcinoids, neuroendocrine tumors originate from diffuse endocrine cells, can involve any part of the gastrointestinal tract, endocrine pancreas and bronchopulmonary (BP) tree, and have a wide range of malignant potential. This chapter summarizes the data available on the epidemiology of neuroendocrine neoplasia (NEN) from around the world, including the relative frequency according to organ of origin, annual incidence rates (IR) and trends in IR at the various anatomic sites, age and stage at presentation, racial and gender differences in IR and 5-year survival rates. Over time, changes have been made in the classification and registration of NEN, both in the same registry and across the globe, thus confounding the possibility to draw conclusions as to the true rise in IR of NEN that is observed all over the world. BP NEN has become the most common site in many western countries, while NEN of the rectum is more common in the Far East. In some countries, appendiceal NEN is the most common site in females. When compared to adenocarcinoma of the same location, the prognosis of NEN patients is better. Five-year survival rates are highest for NEN originating in the rectum and appendix, but lower in small intestinal and pancreatic NEN. Future research is needed to understand the contribution of genetic and environmental factors to NEN epidemiology.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26303701     DOI: 10.1159/000381970

Source DB:  PubMed          Journal:  Front Horm Res        ISSN: 0301-3073            Impact factor:   2.606


  14 in total

Review 1.  Surgical management of neuroendocrine tumor-associated liver metastases: a review.

Authors:  Miu Yee Chan; Ka Wing Ma; Albert Chan
Journal:  Gland Surg       Date:  2018-02

2.  Orbital metastases from neuroendocrine neoplasms: clinical implications and outcomes.

Authors:  Lukasz Kamieniarz; Eleni Armeni; Luke Furtado O'Mahony; Charlotte Leigh; Lukon Miah; Akshay Narayan; Ankit Bhatt; Nicholas Cox; Dalvinder Mandair; Shaunak Navalkissoor; Martyn Caplin; Christos Toumpanakis
Journal:  Endocrine       Date:  2019-11-15       Impact factor: 3.633

3.  Comparison of characteristics between true rectal neuroendocrine tumors and rectal hyperplastic polyps among patients with endoscope-diagnosed rectal neuroendocrine tumors.

Authors:  Yan Weng; Jingxue Ran; Yongmei Peng; Yining Xiang; Liangbi Xu
Journal:  J Gastrointest Oncol       Date:  2022-06

4.  Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy.

Authors:  Rudolf A Werner; Harun Ilhan; Sebastian Lehner; László Papp; Norbert Zsótér; Imke Schatka; Dirk O Muegge; Mehrbod S Javadi; Takahiro Higuchi; Andreas K Buck; Peter Bartenstein; Frank Bengel; Markus Essler; Constantin Lapa; Ralph A Bundschuh
Journal:  Mol Imaging Biol       Date:  2019-06       Impact factor: 3.488

Review 5.  Multilayered heterogeneity as an intrinsic hallmark of neuroendocrine tumors.

Authors:  Sergio Pedraza-Arévalo; Manuel D Gahete; Emilia Alors-Pérez; Raúl M Luque; Justo P Castaño
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

6.  High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors.

Authors:  Bo Zhou; Jie Xiang; Ming Jin; Xiang Zheng; Guogang Li; Sheng Yan
Journal:  BMC Cancer       Date:  2021-03-31       Impact factor: 4.430

7.  Lutetium oxodotreotide (177Lu-Dotatate) for the treatment of unresectable or metastatic progressive gastroenteropancreatic neuroendocrine tumors: a cost-effectiveness analysis for Scotland.

Authors:  J Smith-Palmer; O R Leeuwenkamp; J Virk; N Reed
Journal:  BMC Cancer       Date:  2021-01-05       Impact factor: 4.430

Review 8.  Integrative Concepts for Liver Surgery.

Authors:  Stefan Heinrich; Felix Watzka; Hauke Lang
Journal:  Visc Med       Date:  2020-09-17

9.  Neuroendocrine tumors in Panama: A nationwide database analysis.

Authors:  Moises Cukier; Ruth Vergara; Jorge D Mendez-Rios; Omar Castillo; Irma Barrera; Eliecer Tello; Olivia El Achtar; Yong Loo; Hector Tapia; Guadalupe Perez; Maximino Peña
Journal:  Mol Clin Oncol       Date:  2021-06-11

10.  Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors.

Authors:  Ashley L Titan; Jeffrey A Norton; Andrea T Fisher; Deshka S Foster; E John Harris; David J Worhunsky; Patrick J Worth; Monica M Dua; Brendan C Visser; George A Poultsides; Michael T Longaker; Robert T Jensen
Journal:  JAMA Netw Open       Date:  2020-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.